Loading...
XNYS
VTR
Market cap39bUSD
Oct 08, Last price  
81.76USD
1D
2.15%
1Q
-9.82%
Jan 2017
30.77%
Name

Ventas Inc

Chart & performance

D1W1MN
XNYS:VTR chart
P/E
158.12
P/S
6.81
EPS
0.52
Div yield, %
2.35%
Shrs. gr., 5y
4.21%
Rev. gr., 5y
8.98%
Revenues
5.83b
+18.47%
418,449,000771,791,000929,766,000931,575,0001,016,867,0001,764,991,0002,485,299,0002,810,053,0003,075,746,0003,286,398,0003,443,522,0003,574,149,0003,745,810,0003,872,750,0003,795,357,0003,828,007,0004,129,193,0004,497,827,0004,924,266,0005,833,980,000
Net income
251m
+209.76%
131,430,000282,318,000226,288,000266,495,000246,167,000364,493,000362,800,000453,509,000475,767,000417,843,000649,231,0001,356,470,000409,467,000433,016,000439,149,00049,008,000-47,447,000-40,973,00081,153,000251,381,000
CFO
1.68b
+25.59%
268,656,000399,810,000379,907,000422,101,000447,622,000773,197,000992,816,0001,194,755,0001,254,845,0001,391,767,0001,367,457,0001,434,921,0001,438,922,0001,437,955,0001,450,176,0001,043,963,0001,148,474,0001,194,543,0001,337,993,0001,680,426,000
Dividend
Sep 30, 20260.52 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ventas, an S&P 500 listed enterprise, occupies a distinctive position at the convergence of the healthcare and real estate industries. As a globally recognized leader among Real Estate Investment Trusts (REITs), the company strategically deploys its financial resources to enhance the inherent value of its property assets. Ventas cultivates strong alliances with prominent care providers, innovative developers, leading research and medical institutions, and other healthcare organizations, all of whom benefit from the significant market driver of an aging global demographic. For over two decades, Ventas has pursued a consistent and effective operational framework. This strategy involves building a high-quality, diverse portfolio of properties complemented by various capital sources, enabling the company to successfully navigate economic fluctuations. Ventas emphasizes collaborative engagements with industry-leading partners and relies on an experienced, unified team focused on generating stable, growing cash flows and superior returns for its shareholders, all supported by a robust balance sheet. As of September 30, 2020, Ventas's extensive holdings included approximately 1,200 properties, either directly owned or managed through unconsolidated joint ventures.

Related entities

Subsidiaries (34)
LS UCITY ACADEMIC REIT, LLC
LS UCITY ACADEMIC UT, LLC
NHP BLACKSTONE LLC
NHP CHESTNUT HILL LLC
NHP HARWICH LLC
NHP MELBOURNE LLC
NHP NORTON LLC
NHP SHARON LLC
NHP WESTON LLC
Ventas SSL Holdings Finance, LLC
Ventas UK II, LLC
VTRAZ SACRAMENTO, LP
WE 100 COLLEGE STREET LLC
WEXFORD-UCSC 3737, LLC

Key people

Chief Financial Officer, Executive Vice President · since 2015
Peter J. Bulgarelli
Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. · since 2018
John D. Cobb
Executive Vice President, Chief Investment Officer · since 2013
Chairman of the Board, Chief Executive Officer · since 2010
Jay M. Gellert
Independent Director · since 2001
Independent Director · since 2011
Roxanne M. Martino
Independent Director · since 2016
Independent Director · since 2019
Independent Director · since 2016
Robert D. Reed
Independent Director · since 2008
Presiding Independent Director · since 2016
IPO date
Apr 02, 1992
Employees
451
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
500 Hurstbourne Parkway
Suite 200
Louisville, KY 40222
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT